Aaqib Sohail,Azeem A. Iqbal,Nishika Sahini,Fangfang Chen,Mohamed Tantawy,Syed F.H. Waqas,Moritz Winterhoff,Thomas Ebensen,Kristin Schultz,Robert Geffers,Klaus Schughart,Matthias Preusse,Mahmoud Shehata,Heike Bähre,Marina C. Pils,Carlos A. Guzman,Ahmed Mostafa,Stephan Pleschka,Christine Falk,Alessandro Michelucci,Frank Pessler,Aaqib Sohail,Azeem A. Iqbal,Nishika Sahini,Fangfang Chen,Mohamed Tantawy,Syed F.H. Waqas,Moritz Winterhoff,Thomas Ebensen,Kristin Schultz,Robert Geffers,Klaus Schughart,Matthias Preusse,Mahmoud Shehata,Heike Bähre,Marina C. Pils,Carlos A. Guzman,Ahmed Mostafa,Stephan Pleschka,Christine Falk,Alessandro Michelucci,Frank Pessler

Abstract:Excessive inflammation is a major cause of morbidity and mortality in many viral infections including influenza. Therefore, there is a need for therapeutic interventions that dampen and redirect inflammatory responses and, ideally, exert antiviral effects. Itaconate is an immunomodulatory metabolite which also reprograms cell metabolism and inflammatory responses when applied exogenously. We evaluated effects of endogenous itaconate and exogenous application of itaconate and its variants dimethyl- and 4-octyl-itaconate (DI, 4OI) on host responses to influenza A virus (IAV). Infection induced expression of ACOD1, the enzyme catalyzing itaconate synthesis, in monocytes and macrophages, which correlated with viral replication and was abrogated by DI and 4OI treatment. In IAV-infected mice, pulmonary inflammation and weight loss were greater in Acod1 -/- than in wild-type mice, and DI treatment reduced pulmonary inflammation and mortality. The compounds reversed infection-triggered interferon responses and modulated inflammation in human cells supporting non-productive and productive infection, in peripheral blood mononuclear cells, and in human lung tissue. All three itaconates reduced ROS levels and STAT1 phosphorylation, whereas AKT phosphorylation was reduced by 4OI and DI but increased by itaconate. Single-cell RNA sequencing identified monocytes as the main target of infection and the exclusive source of ACOD1 mRNA in peripheral blood. DI treatment silenced IFN-responses predominantly in monocytes, but also in lymphocytes and natural killer cells. Ectopic synthesis of itaconate in A549 cells, which do not physiologically express ACOD1 , reduced infection-driven inflammation, and DI reduced IAV- and IFNγ-induced CXCL10 expression in murine macrophages independent of the presence of endogenous ACOD1 . The compounds differed greatly in their effects on cellular gene homeostasis and released cytokines/chemokines, but all three markedly reduced release of the pro-inflammatory chemokines CXCL10 (IP-10) and CCL2 (MCP-1). Viral replication did not increase under treatment despite the dramatically repressed IFN responses. In fact, 4OI strongly inhibited viral transcription in peripheral blood mononuclear cells, and the compounds reduced viral titers (4OI>Ita>DI) in A549 cells whereas viral transcription was unaffected. Taken together, these results reveal itaconates as immunomodulatory and antiviral interventions for influenza virus infection.

Influenza A virus infection induces indoleamine 2,3-dioxygenase (IDO) expression and modulates subsequent inflammatory mediators in nasal epithelial cells

Inhibition of Indoleamine 2,3-Dioxygenase Enhances the T-cell Response to Influenza Virus Infection.

Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza a Virus Infection.

Aromatic amino acid metabolites alter interferon signaling and influenza pathogenesis

Epigoitrin, an Alkaloid From Isatis indigotica , Reduces H1N1 Infection in Stress-Induced Susceptible Model in vivo and in vitro .

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

Epigenetic Changes Mediated by Microrna Mir29 Activate Cyclooxygenase 2 and Lambda-1 Interferon Production During Viral Infection.

IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling

Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs

The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD

Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection

Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signaling

Activation of the Interleukin-34 Inflammatory Pathway in Response to Influenza A Virus Infection.

Assessment of neopterin and indoleamine 2,3‐dioxygenase activity in patients with seasonal influenza: A pilot study

Signals from intestinal microbiota mediate the crosstalk between the lung-gut axis in an influenza infection mouse model

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity

Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infection

Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection.

Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1

IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1

Transcriptome Profiling Reveals Differential Effect of Interleukin-17A Upon Influenza Virus Infection in Human Cells.